AL
ANIK icon

AJO LP’s Anika Therapeutics ANIK Stock Holding History

AJO LP’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-36,199
Closed -$1.28M – 292
2020
Q3 		$1.28M Sell
36,199
-84,696
-70% -$3.06M 0.01% 436
2020
Q2 		$4.56M Sell
120,895
-18,770
-13% -$618K 0.04% 282
2020
Q1 		$4.04M Sell
139,665
-50,596
-27% -$2.05M 0.04% 269
2019
Q4 		$9.86M Buy
190,261
+1,720
+0.9% +$99.9K 0.06% 220
2019
Q3 		$10.3M Buy
188,541
+124,843
+196% +$6.41M 0.06% 212
2019
Q2 		$2.59M Buy
+63,698
New +$2.32M 0.01% 386
2017
Q1 		– Sell
-84,574
Closed -$4.14M – 524
2016
Q4 		$4.14M Sell
84,574
-9,646
-10% -$446K 0.02% 290
2016
Q3 		$4.51M Buy
94,220
+79,699
+549% +$3.94M 0.02% 289
2016
Q2 		$779K Buy
+14,521
New +$684K ﹤0.01% 419

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

AJO LP's ANIK Position: Q4 2020 in Review

AJO LP sold out of Anika Therapeutics (ANIK) in Q4 2020, closing a stake of 36,199 shares — an estimated $1.28M sold.

AJO LP first reported a position in ANIK in Q2 2016 and held it in 9 quarters. The position peaked at $10.3M in Q3 2019. 164 funds tracked by Wall St. Rank hold ANIK as of Q4 2020.

  • AJO LP reported no remaining Anika Therapeutics position as of Q4 2020 after selling out during the quarter.
  • AJO LP sold 36,199 Anika Therapeutics shares in Q4 2020, an estimated $1.28M.
  • AJO LP first reported a position in Anika Therapeutics in Q2 2016 and held it in 9 quarters.
  • AJO LP's Anika Therapeutics position peaked at $10.3M in Q3 2019.
  • 164 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2020.

Based on AJO LP's 13F filing for Q4 2020, filed 5 Feb 2021.